GLP-1 receptor agonists obesity drugs market captured the largest revenue share of 81% in 2024 within North America, driven by high obesity prevalence, early drug approvals, and robust healthcare infrastructure
That stress can trigger a condition called telogen effluvium which leads to decrease in hair growth and subsequent hair loss, explains Deena Adimoolam, M.D., an endocrinologist at Summit Health
Weight-loss drugs have been back in the news this week
Mechanism of Action: Semaglutide works by binding to GLP-1 receptors, which are found on pancreatic beta cells
Figure 10.Change from Baseline (%) in BMI in Pediatric Patients with Obesity Aged 12 Years and Older in Study 7 Observed values for patients completing each scheduled visit, and estimates with multiple imputations from retrieved dropouts (RD-MI) Figure 11.Change in BMI (%) from Baseline to Week 68 in Pediatric Patients with Obesity Aged 12 Years and Older in Study 7 Observed data from in-trial period including imputed data for missing observations (RD-MI) Effect of WEGOVY on Anthropometry and Cardiometabolic Parameters in Pediatric Patients with Obesity Aged 12 Years and Older Changes in waist circumference and cardiometabolic parameters with WEGOVY are shown in Table 14 for the study in pediatric patients aged 12 years and older
Furthermore, due to the retrospective design and limitations in our study, RCTs or database analysis in a larger number of patients may be the next step to get more robust conclusions
